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Abstract
Background: Nanoemulsions have practical application in a multitude of commercial areas, such as the chemical,
pharmaceutical and cosmetic industries. Cosmetic industries use rice bran oil in sunscreen formulations, anti ageing
products and in treatments for skin diseases. The aim of this study was to create rice bran oil nanoemulsions using
low energy emulsification methods and to evaluate their physical stability, irritation potential and moisturising
activity on volunteers with normal and diseased skin types.
Results: The nanoemulsion developed by this phase diagram method was composed of 10% rice bran oil, 10%
surfactants sorbitan oleate/PEG-30 castor oil, 0.05% antioxidant and 0.50% preservatives formulated in distilled
water. The nanoemulsion was stable over the time course of this study. In vitro assays showed that this formulation
has a low irritation potential, and when applied to human skin during in vivo studies, the nanoemulsion improved
the skin’s moisture and maintained normal skin pH values.
Conclusion: The results of irritation potential studies and in vivo assessments indicate that this nanoemulsion has
potential to be a useful tool to treat skin diseases, such as atopic dermatitis and psoriasis.
Background
Nanoemulsions are obtained when the size of an emulsion
globule reaches approximately 20-500 nm. The small dro-
plet size can resist the physical destabilisation caused by
gravitational separation, flocculation and/or coalescence. It
also avoids the creaming process because the droplet’s
Brownian motion is enough to overcome the gravitational
separation force [1,2]. The size and polydispersity of
nanoemulsions can affect properties such as particle stabi-
lity, rheology, appearance, colour, texture and shelf life [3].
In nanoemulsions, the most frequent instability phenom-
enon is Ostwald ripening [4,5], which can be calculated
according to the Lifshitz-Slezov and Wagner theory
(LSW) using the following equation [6,7]:
ω =
dr3n
dt
= k
Dc∞γM
ρ2RT
(1)
Where ω is defined as the rate of change of the cube of
the number average radius, D is the diffusion coefficient
of the dispersed oil phase in the aqueous phase, g is the
interfacial tension between the two phases, c∞ is the bulk
solubility of the oil in the water and r is the oil density. k
is a constant that has the value of 8/9 in the LSW.
Nanoemulsions are well characterised and are a promis-
ing drug delivery system with practical applications for
pharmaceutical, cosmetic and chemical industry applica-
tions. They have been used in intravenous, oral and ocular
drug administrations and have reduced drug side effects
and improved the pharmacological effects of the drugs
given [8-10,4]. Nanoemulsions are primarily produced
either by high-energy emulsification (e.g., high-pressure
homogenisation) or by low-energy emulsification (using
physicochemical properties of the components) [11]. This
work focuses on the latter method for nanoemulsion
synthesis.
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Rice (Oryza sativa) bran oil has unsaponifiable fractions
that contain high levels of antioxidant-rich components,
such as tocopherols/tocotrienols and gamma-oryzanol,
which could be useful for topical formulations [12]. The
cosmetics industry has used rice bran oil in sunscreen for-
mulations [13], in topical aging prevention products [14]
and in treatments for skin diseases [15].
When skin is affected by diseases such as atopic derma-
titis and psoriasis, it exhibits a compromised skin barrier
function that causes increased transepidermal water loss
[16-18]. Moisturisers can help improve the skin’s func-
tion by relieving the cutaneous manifestations of these
diseases [18-20]. Measuring the stratum corneum (SC)
hydration degree gives important information about the
biophysical properties and the function of the skin [21].
In vitro studies, such as the HET-CAM (Hen’s Egg
Test on the Chorioallantoic Membrane), are used to
evaluate cosmetics products by immediately showing
whether or not a solid or liquid substance irritates the
hen’s egg chorioallantoic membrane [22].
The aim of this study was to obtain nanoemulsions of
rice bran oil and to evaluate their physical stability, irri-
tating potential and in vivo moisturising activity.
Materials and methods
Materials
Sorbitan oleate (HLB 4.3) and rice bran oil were kindly
provided from Lipo do Brasil (Brazil). PEG-30 castor oil
(HLB 11.7) was donated by Oxiteno (Brazil). The preserva-
tive DMDM Hydantoin (and) Iodopropynyl Butylcarba-
mate (Glydant® plus) was obtained from Chemyunion
(Brazil), and the antioxidant Butyl Hydroxy Toluene
(BHT) was purchased from Synth (Brazil).
Preparation of nanoemulsion
The following surfactant mixtures were evaluated to find a
stable nanoemulsion formulation: polysorbate 80/sorbitan
oleate, polysorbate 60/sorbitan oleate, ceteareth-20 OE/
ceteth-2, PEG-15 castor oil/sorbitan oleate, PEG-30 castor
oil/sorbitan oleate and PEG-40 castor oil/sorbitan oleate.
The PEG-30 castor oil/sorbitan oleate (HLBresulting= 8.0)
was the only surfactant combination that resulted in a
stable formulation and therefore was chosen for further
study.
The phase diagram method was used with different
concentration of constituents to result in 42 different
emulsion formulations. All emulsions were prepared
according the Emulsion Phase Inversion (EPI) method,
where the water and oil phases were heated separately
at 75°C, the water phase was added into the oil phase
(rice bran oil and surfactants) while stirring at 600 rpm
(Fisatom, 713-Dmodel, Brazil), and the mixture was
then cooled to 25°C while stirring.
Determination of nanoemulsion droplet size
The mean droplet size and polydispersity index of the
nanoemulsions were determined by dynamic light scat-
tering (DLS) (Zetasizer, modelo ZS, Malvern Instru-
ments, UK). Measurements were performed at 25°C
using a scattering angle of 90°. Samples were considered
polydisperse when the polydispersity index was higher
than 0.2 [23].
Stability study
The preliminary stability of the nanoemulsion prepara-
tion was evaluated at 24 hours by centrifuge and thermal
stress analyses. Stability was assessed by macroscopic
emulsion observation and droplet size analysis. The pur-
pose of these tests was to select a stable, low-surfactant
formulation with a nanoemulsion-size droplet and stable
physicochemical properties. The selected nanoemulsion
was prepared in triplicate, and the samples were stored at
25 ± 2°C, 40 ± 2°C and 5 ± 2°C. Tests were performed at
24 hours, 7, 15, 30, 60 and 90 days after preparation. The
analysis measurements were droplet size, pH value and
electrical conductivity.
Physical-chemical analyses
To perform the thermal stress test, nanoemulsions were
heated in an ultra bath thermostat (Nova Técnica, Brazil)
at temperatures ranging from 40 to 80°C. The temperature
was increased by 5°C every 30 minutes. The nanoemul-
sions were centrifuged (Fanem 206-R, Brazil) at 1000,
2500 and 3500 rpm (70, 440 and 863 G, respectively) for
15 minutes in each rotation to accelerate possible instabil-
ity phenomena. A pH meter (PM608 model - Analion,
Brazil) was used to measure the pH of the nanoemulsions
at 25 ± 2°C. The electrical conductivity was evaluated at
25 ± 2°C by a portable conductivity meter (mCA-150
model, Tecnopon, Brazil).
Irritant test in an organotypic model - HET-CAM (Hen’s
Egg Test on the Chorioallantoic Membrane)
The HET-CAM test is routinely used to evaluate the
potential eye irritation of raw materials but can in some
cases be used to evaluate skin irritation, e.g. in the case
of surfactants. Irritation causes alterations in the vascu-
lar system of the HET-CAM that result in membrane
discoloration, haemorrhaging and increased perfusion.
The method used in this manuscript is a modification of
the method described by Luepke [24] and adapted by
Mehling [25] that allows the immediate evaluation of
irritation by solid or liquid substances in the hen’s egg
chorioallantoic membrane. Each substance was tested
on three fertilised eggs that were incubated for 9 days
prior to testing. The CAM (Chorioallantoic Membrane)
was exposed to 300 μL of one of the following
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substances: (1) nanoemulsion (pH 6.54), (2) surfactant
solution blend (5% sorbitan oleate, 5% PEG-30 castor oil
and 90% water (pH 6.32), (3) Sodium lauryl sulphate
(SLS) 10% w/w (positive control, pH 6.05) and (4) saline
solution (negative control, pH 6.0). The CAM was
rinsed with physiological saline solution after 30 seconds
of exposure to each substance, and the intensity of the
reactions (hyperaemia, haemorrhage and coagulation)
was semi-quantitatively assessed on a scale of 0.5, 2 and
5 minutes after treatment; longer observation times give
no additional important information. The numerical
time-dependent scores for hyperaemia, haemorrhage
and coagulation are summed to give a single numerical
value indicating the irritation potential of the test sub-
stance on a scale with a maximum value of 21. The
mean value of four tests makes possible an assessment
by a classification scheme analogous to the Draize cate-
gories (Table 1).
In vivo assessment
Approval to conducted the in vivo studies was obtained
from the Ethics Committee of Faculdade de Ciências
Farmacêuticas de Ribeirão Preto, Ribeirão Preto, São
Paulo, Brazil, under protocol number CEP/FCFRP n°. 147.
Seventeen Caucasian volunteers with healthy skin (all
women, 20-29 years old), five patients with atopic dermati-
tis (all women, 21-30 years old), and four psoriasis patients
(1 man and 3 women, 28-56 years old) without skin
lesions on the forearm were included in the study. The
forearm area was washed with mild soap two hours before
the analysis. The volunteers were kept for 10 min in a con-
trolled room at ambient temperature (25 ± 2°C; 29-34%
relative humidity) before starting the assay. Baseline values
were determined using a Corneometer CM 820, a Sebu-
meter SM 810 and a Skin-pH-meter PH 900 instruments
(Courage &Khazaka, Köln, Germany) before applying the
formulation. Then, 50 μL of nanoemulsion was applied to
the right forearm in three rectangular areas of 13.80 cm2
and distributed for 20 seconds by rubbing the test area
using a circular motion. Excess nanoemulsion was left on
the skin. The treated skin of each patient was measured
30, 60, 90, 120 and 150 minutes after nanoemulsion appli-
cation, with one measure for sebum content and triplicate
measurements of electrical capacitance and skin pH.
Results and discussion
Preparation of nanoemulsion
The phase diagram with the rice bran oil, surfactants sor-
bitan oleate/PEG-30 castor oil and water shows formation
of five different areas: (I) O/W (Oil/Water) nanoemulsion,
(II) phase separation, (III) gel phase, (IV) W/O (Water/
Oil) emulsions and (V) O/W emulsions (Figure 1).
Table 2 shows the composition and the droplet size of
the nanoemulsion systems.
All of the nanoemulsions (Table 2) were stable when
tested using the centrifugation test. The only formulation
that showed signs of instability at high temperatures
(70°C) was the nanoemulsion composed of 10:20:70 (oil,
surfactants and water, respectively).
A surfactant concentration of 5.00% was not sufficient
to form a nanoemulsion, even with smaller amounts of
oil. The surfactant amount affects the stabilisation and
size of the emulsion droplets. From the experimental
results, the nanoemulsion that used the lowest possible
surfactant concentration while still maintaining thermal
stability, centrifugal stability and small droplet size was
selected as the working formulation.
Based on these preliminary results, we chose a formu-
lation composed of 10% rice bran oil, 10% surfactant
blend and 80% water and proceeded with further stabi-
lity tests and in vitro and in vivo evaluations.
Stability study
The formulation composed of 10:10:80 (rice bran oil,
surfactant blend and water) was supplemented with
0.05% antioxidants and 0.50% preservatives. The formu-
lation was tested at three different storage temperatures:
25 ± 2°C, 40 ± 2°C and 5 ± 2°C. By granulometric analy-
sis the particles maintained a mono-disperse, monomo-
dal peak after 24 hours (Figure 2). The formulation was
stable for up to 90 days as determined by macroscopic
analysis.
Droplet size measurements are a good indicator of the
formulation stability. A fast droplet size increase indicates
low system stability. The droplet size for this formulation
remained constant over 90 days for all temperature condi-
tions (Figure 3).
The nanoemulsions had polydispersity index values
below 0.2 throughout the 90-day testing period, indicat-
ing the high fidelity of the system (low polydispersity),
which may reflect the overall stability of this formulation
and synthesis method. Polydispersity values near 1.0 are
indicative of a polydisperse system [26]. The long term
stability of nanoemulsions was previously evaluated and
was also verified by stability studies conducted over three
months. The W/O nanoemulsion produced by low
energy emulsification showed no difference in droplet
size over the study period at both 25°C and 4°C [27]. The
W/O nanoemulsion demonstrated high physical stability,
Table 1 Classification of cumulative scores in the
chorioallantoic membrane test (According Luepke 1985
[24])
Cumulative Score Irritation assessment
0-0.9 Practically none
1-4.9 Slight
5-8.9 Moderate
9-21 Strong
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corroborating our results for temperatures of 5 ± 2°C and
25 ± 2°C.
Low-energy emulsification is better at producing
stable nanoemulsions than its higher energy counterpart.
When nanoemulsions were prepared using a high pres-
sure homogeniser, the droplet size was initially around
100 nm; however, the particles increased in size after 30
days at either 25 or 4°C. This phenomenon was attribu-
ted to the preparation method [28]. The low-energy
emulsification method used in our study showed high
stability with respect to the droplet size and polydisper-
sity index.
pH value determination
Monitoring the pH value is important for determining
the emulsions’ stability because pH changes indicate the
occurrence of chemical reactions that can compromise
the quality of the final product. Emulsions produced with
vegetable oils may experience a decrease in pH due to
the hydrolysis of fatty acid esters into free fatty acid
degradation products [29].
The nanoemulsions had stable pH values for almost
all conditions tested (Figure 4). Only at a temperature of
40 ± 2°C and 90 days of incubation was there a statisti-
cally significant decrease in the pH of the nanoemulsion.
The high temperature might have destabilised the
nanoemulsion by hydrolysis, but it did not affect the
overall quality of the nanoemulsions because the pH
values remained around pH 6.0, which is an acceptable,
non-skin irritating pH value.
Electrical conductivity
The nanoemulsion showed changes in electrical conduc-
tivity at all storage conditions (Figure 5).
Figure 1 Phase diagram with rice bran oil, sorbitan oleate/PEG-30 castor oil and water. Region I: nanoemulsion, II: phase separation, III: gel
phase, IV: W/O emulsions; V: O/W emulsions.
Table 2 Composition of formulation characterised as nanoemulsions
Rice bran oil (% w/w) Sorbitan oleate/PEG-30 castor oil (% w/w) Purified water (% w/w) Droplet size (nm) ± (Standard Deviation)
10.00 30.00 60.00 91 ± 19
10.00 20.00 70.00 45 ± 12
10.00 10.00 80.00 69 ± 17
20.00 10.00 70.00 303 ± 32
10.00 15.00 75.00 121 ± 13
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Changes in the electrical conductivity can indicate
nanoemulsion instability and may influence the nanoe-
mulsion droplet size [30]. In these studies, changes in
electrical conductivity did not affect the nanoemulsion
droplet size (Figure 3). It is difficult to assess the emul-
sion stability solely by electrical conductivity because
the relationship between an increase in electrical con-
ductivity and emulsion instability is not linear [31].
Thus, we could not conclusively determine the nanoe-
mulsion’s stability by this parameter. However, because
the particle size and the pH value did not significantly
change across different conditions, we considered our
nanoemulsion to be stable. Nanoemulsion stability is a
crucial parameter in determining the moisturising activ-
ity of the nanoemulsions in vivo.
Irritant test in an organotypic model - HET-CAM (Hen’s
Egg Test on the Chorioallantoic Membrane)
Topical application products must have a low ocular/
mucous membrane and a low dermal irritation potential.
Figure 2 Droplet size distribution of nanoemulsions after 24 hours.
Figure 3 Nanoemulsion droplet size under different storage conditions during a 90-day stability test.
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The irritation potential depends on the concentration of
the substance as well as the chemical composition and
the pH of the formulation [25].
The HET-CAM test can help evaluate the irritation
potential of substances in vitro and in vivo [32]. The
CAM showed no signs of irritation after application of
either the nanoemulsion or the negative control sub-
stance, so the nanoemulsion was therefore considered
practically non-irritating. The surfactant solution by
itself caused mild hyperaemia, which suggests that the
presence of rice bran oil in the nanoemulsion may have
protected the chorioallantoic membrane from the irritat-
ing effects of the surfactant solution (Table 3). The pH
values were the same for all samples tested to eliminate
pH as a variable in the HET-CAM results.
Previous studies showed that O/W microemulsions
containing linoleic acid were only barely irritating in the
HET-CAM test, indicated by a slight discoloration of the
chorioallantoic membrane [33]. The HET-CAM test
showed that the nanoemulsion containing rice bran oil
was essentially non-irritating.
In vivo assessment
The formulation composed of 10:10:80 (rice bran oil,
surfactant blend and water) was chosen for the in vivo
study due to its high stability and lack of irritation in
Figure 4 pH values for nanoemulsions over time under different storage conditions.
Figure 5 Electrical conductivity of nanoemulsions over time under different storage conditions.
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the HET-CAM test. This nanoemulsion formulation was
applied to volunteers with either normal or affected skin
(atopic dermatitis or psoriasis).
Moisturising activity
The moisturising activity of the stratum corneum is mea-
sured by skin capacitance. It is also an important tool in
evaluating healthy and diseased skin such as patients
with atopic dermatitis or psoriasis [34-36]. The moistur-
ising variance in healthy volunteers increased both
30 and 60 minutes after nanoemulsion application and
then decreased over the remainder of the study. Volun-
teers with atopic dermatitis or psoriasis showed increased
moisturising variance in the first 30 minutes and main-
tained this increase up to 90 minutes after application.
Then, the moisturising capacitance decreased after
90 minutes until the end of test (Figure 6). Skin affected
by atopic dermatitis or psoriasis had a lower basal hydra-
tion value compared with healthy skin. People with these
drying skin conditions have increased dryness in their
skin outside of the regions with lesions [37-39]. The rice
bran oil nanoemulsion increased the moisturising var-
iance by about 38% in normal skin volunteers and by
30% in volunteers with atopic dermatitis or psoriasis,
which is a satisfactory result because a high-quality com-
mercial moisturiser only increased skin hydration by
about 20% after 14 days of application [40]. These
improved effects may be caused by the nanoemulsion
droplets adhering to the skin and forming a dense film
that inhibits water evaporation from the skin [41].
The rice bran oil nanoemulsion significantly increased
the skin hydration in volunteers suffering from atopic
dermatitis and psoriasis. Although the skin hydration
measurements should be conducted over a longer period
of time, 8 - 24 h, this study indicates that the nanoemul-
sion may provide long-term skin hydration.
Oily Skin
The oiliness values of nanoemulsion-treated skin
increased considerably 30 minutes after treatment and
then decreased in both the healthy and affected skin
groups. The increase may be related to the amount of
rice bran oil (10%) in the formulation (Figure 7). Cos-
metic emulsions form an oily layer on the skin that can
protect the lipid barrier, which is desirable in dry skin
conditions [42]. Therefore, the oiliness of the nanoemul-
sion may provide an alternative treatment for psoriasis.
Skin pH determination
Forearm skin testing is standard in most clinical studies of
skin and has pH values in the range of 4.2 to 5.9 for both
sexes [43]. The pH values of volunteers’ skin tested during
this study ranged from 4.9 to 5.2 after treatment for both
groups. Thus, the pH changes due to the nanoemulsion
Table 3 Scores and assessments of irritation potential of
nanoemulsions and surfactant solution tested in the
chorioallantoic membrane test
Formulation Cumulative Score (average) Assessment
Nanoemulsion1 0 Practically none
Surfactant Solution2 5 Moderate
Positive control3 15 Strong
Negative control4 0 Practically none
110.00% of rice bran oil, 5.00% of sorbitan oleate, 5.00% of PEG-30 castor oil,
0.05% of BHT antioxidant, 0.50% of preservative and 79.45% of distilled water
25.00% of sorbitan oleate, 5.00% of PEG-30 castor oil and 90.00% of distilled
water
310% of SLS and 90% of distilled water
4Saline solution
Figure 6 Moisturising variance after nanoemulsion treatment in volunteers with either normal skin or skin affected by atopic
dermatitis or psoriasis.
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were within the accepted pH range for forearm skin found
in the literature, so this formulation does not significantly
alter the skin pH (Figure 8).
Conclusion
The nanoemulsion developed in this study using the
phase diagram method was composed of 10% rice bran
oil, 10% surfactants sorbitan oleate/PEG-30 castor oil,
0.05% antioxidants and 0.50% preservatives formulated
in distilled water. The nanoemulsion was stable during
the period of study and was found to be practically
non-irritating in the organotypic HET-CAM model.
When applied to the skin of volunteers, the nanoemul-
sion increased the relative hydration of the skin, the
skin oiliness and maintained normal skin pH values.
This nanoemulsion could serve as an alternative treat-
ment for skin diseases such as atopic dermatitis and
psoriasis.
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